Eli Casdin

Invests in genomics, precision medicine, and life sciences technology companies. Believes genomics will be the defining technology platform of the 21st century, like computing was for the 20th.

Founder and Chief Investment Officer of Casdin Capital, a genomics and life sciences-focused investment firm. Former analyst at Viking Global. One of the most prominent public and private investors in the genomics revolution.